Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.40 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.38 |
| ▸ | PPARD | Q03181 | 4/20 | 0.38 |
| ▸ | PPARA | Q07869 | 4/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18756802 | 0.86 | TGFBR1 (0.41) | TGFBR1HDAC11MEN1KMT2A | |
| SCHEMBL4089048 | 0.86 | TGFBR1 (0.47) | TGFBR1KDM4CKDM4AKDM2ATSHR | |
| SCHEMBL11747509 | 0.83 | ADH1B (0.46) | FFAR1TGFBR1TSHRGPR84MEN1 | |
| SCHEMBL14219281 | 0.83 | ADH1B (0.46) | FFAR1TGFBR1TSHRGPR84MEN1 | |
| SCHEMBL11675845 | 0.83 | ADH1B (0.46) | FFAR1TGFBR1TSHRGPR84MEN1 | |
| SCHEMBL472265 | 0.83 | ADH1B (0.46) | FFAR1TGFBR1TSHRGPR84MEN1 | |
| SCHEMBL10431575 | 0.82 | ADRA1A (0.50) | FFAR4FFAR1ALDH1A1KDM4CADRA1A | |
| SCHEMBL29089100 | 0.80 | PLA2G2C (0.57) | FFAR4FFAR1ALDH1A1TSHRPLA2G10 | |
| SCHEMBL28643712 | 0.80 | PLA2G2C (0.57) | FFAR4FFAR1ALDH1A1TSHRPLA2G10 | |
| SCHEMBL472236 | 0.79 | TGFBR1 (0.43) | TGFBR1ALDH1A1KDM4CKDM4APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3519493-B1 | RADIATION CURABLE COMPOSITIONS WITH ANTI-STAIN PROPERTIES | ALLNEX Belgium SA (BE) | 2023-08-09 | — | — | EP | disclosed |
| US-11359110-B2 | Radiation curable compositions with anti-stain properties | ALLNEX BELGIUM S.A. (BE) | 2022-06-14 | — | — | US | disclosed |
| US-10995270-B2 | Stabilizer for thiol-ene compositions | ALLNEX BELGIUM S.A. (BE) | 2021-05-04 | — | — | US | disclosed |
| US-20200140616-A1 | STABILIZER FOR THIOL-ENE COMPOSITIONS | ALLNEX BELGIUM S.A. (BE) | 2020-05-07 | — | — | US | disclosed |
| US-20200140755-A1 | STABILIZER FOR THIOL-ENE COMPOSITIONS | ALLNEX BELGIUM S.A. (BE) | 2020-05-07 | — | — | US | disclosed |
| US-10563125-B2 | Stabilizer for thiol-ene compositions | ALLNEX BELGIUM S.A. (BE) | 2020-02-18 | — | — | US | disclosed |
| EP-3532517-A1 | ENERGY CURABLE AQUEOUS COMPOSITIONS | Allnex Belgium S.A. (BE) | 2019-09-04 | — | — | EP | disclosed |
| US-20190233560-A1 | ENERGY CURABLE AQUEOUS COMPOSITIONS | ALLNEX BELGIUM S.A. (BE) | 2019-08-01 | — | — | US | disclosed |
| US-20190218418-A1 | RADIATION CURABLE COMPOSITIONS WITH ANTI-STAIN PROPERTIES | ALLNEX BELGIUM S.A. (BE) | 2019-07-18 | — | — | US | disclosed |
| US-10253206-B2 | Waterborne curing compositions for electrodeposition and radiation curing | ALLNEX BELGIUM S.A. (BE) | 2019-04-09 | — | — | US | disclosed |
| EP-2825603-A1 | ACTIVE ENERGY RAY CURABLE AQUEOUS EMULSIONS | Allnex Belgium, S.A. (BE) | 2015-01-21 | — | — | EP | disclosed |
| US-20140377466-A1 | ACTIVE ENERGY RAY CURABLE AQUEOUS EMULSIONS | ALLNEX BELGIUM S.A. (BE) | 2014-12-25 | — | — | US | disclosed |
| WO-2013135621-A1 | ACTIVE ENERGY RAY CURABLE AQUEOUS EMULSIONS | ALLNEX BELGIUM, S.A. (BE) | 2013-09-19 | — | — | WO | disclosed |
| EP-2639272-A1 | Active energy ray curable aqueous emulsions | Cytec Surface Specialties, S.A. (BE) | 2013-09-18 | — | — | EP | disclosed |
| EP-2598551-A1 | RADIATION CURABLE AQUEOUS COMPOSITIONS | Cytec Surface Specialties, S.A. (BE) | 2013-06-05 | — | — | EP | disclosed |
| US-20130122310-A1 | RADIATION CURABLE AQUEOUS COMPOSITIONS | ALLNEX BELGIUM S.A. (BE) | 2013-05-16 | — | — | US | disclosed |
| WO-2012013488-A1 | RADIATION CURABLE AQUEOUS COMPOSITIONS | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2012-02-02 | — | — | WO | disclosed |
| EP-0857766-B1 | Process for producing aqueous ink for inkjet printing | KAO CORP (JP) | 2005-04-20 | — | — | EP | disclosed |
| US-5998501-A | DISSOLVING POLYMER AND HYDROPHOBIC DYE IN WATER INSOLUBLE SOLVENT; ADDING WATER AND NEUTRALIZING AGENT; EMULSIFICATION; DESOLVENTIZING | KAO CORPORATION (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0857766-A1 | Process for producing aqueous ink for inkjet printing | KAO CORPORATION (JP) | 1998-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10563125-B2 | Stabilizer for thiol-ene compositions | PTMS, CHAMP1, TST | FFAR4 4819/4885FFAR1 4553/4885TGFBR1 1986/4885 |
| US-10995270-B2 | Stabilizer for thiol-ene compositions | PTMS, CHAMP1, TST | FFAR4 4819/4885FFAR1 4553/4885TGFBR1 1986/4885 |
| US-20200140755-A1 | STABILIZER FOR THIOL-ENE COMPOSITIONS | PTMS, CHAMP1, TST | FFAR4 4819/4885FFAR1 4553/4885TGFBR1 1986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.